CiVi Biopharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.civibio.com
Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy
- First Posted Date
- 2019-11-15
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Civi Biopharma, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT04164888
- Locations
- 🇺🇸
Research Site, San Antonio, Texas, United States
A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Civi Biopharma, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03427710
- Locations
- 🇬🇧
Leeds Clinic, Leeds, West Yorkshire, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath